rdbio (仁度生物 / Rendo Biotech)
Rendo Biotech (仁度生物) is a Shanghai-based molecular diagnostics company founded in 2007 and listed on China's STAR Market (Science and Technology Innovation Board, stock code 688193). It specializes in pathogen RNA clinical detection, developing diagnostic reagents and fully automated nucleic-acid analysis instruments across five clinical areas — reproductive-health screening, bloodborne pathogen detection, respiratory infections, enterovirus identification, and food safety. The company serves 700+ medical institutions and holds 74+ invention patents. It was surfaced as a portfolio company of the Qiming Venture Partners network and added to the API Evangelist network. As of this enrichment pass, Rendo Biotech publishes no public developer API, OpenAPI definition, SDK, or documentation surface — it is a diagnostics-instrument and reagents manufacturer, not an API provider.
rdbio (仁度生物 / Rendo Biotech) is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Molecular Diagnostics, Clinical Diagnostics, and Life Sciences.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Company 1
The organization behind the API